Glycosorb® ABO

Glycosorb® ABO is a medical device that enables organ transplants across the blood group barrier. Since the first transplant in 2001, the treatment method has shown to be effective, gentle and safe for the patient and is used for both adults and children. Glycosorb® ABO is used primarily for kidney transplants, but also for transplantations of stem cells, liver, heart and lungs. Since its inception, Glycosorb® ABO has been used in more than 6,000 transplants with excellent medical results, presented in over 60 articles in reputable medical journals.